Style | Citing Format |
---|---|
MLA | Getso MI, et al.. "Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals." Journal of Chemical Health Risks, vol. 11, no. 3, 2021, pp. 271-282. |
APA | Getso MI, Raissi V, Karami MF, Alizadeh G, Zareie M, Samani ZB, Bayat F, Raiesi O, Etemadi S (2021). Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals. Journal of Chemical Health Risks, 11(3), 271-282. |
Chicago | Getso MI, Raissi V, Karami MF, Alizadeh G, Zareie M, Samani ZB, Bayat F, Raiesi O, Etemadi S. "Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals." Journal of Chemical Health Risks 11, no. 3 (2021): 271-282. |
Harvard | Getso MI et al. (2021) 'Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals', Journal of Chemical Health Risks, 11(3), pp. 271-282. |
Vancouver | Getso MI, Raissi V, Karami MF, Alizadeh G, Zareie M, Samani ZB, et al.. Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals. Journal of Chemical Health Risks. 2021;11(3):271-282. |
BibTex | @article{ author = {Getso MI and Raissi V and Karami MF and Alizadeh G and Zareie M and Samani ZB and Bayat F and Raiesi O and Etemadi S}, title = {Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals}, journal = {Journal of Chemical Health Risks}, volume = {11}, number = {3}, pages = {271-282}, year = {2021} } |
RIS | TY - JOUR AU - Getso MI AU - Raissi V AU - Karami MF AU - Alizadeh G AU - Zareie M AU - Samani ZB AU - Bayat F AU - Raiesi O AU - Etemadi S TI - Toxoplasmosis Among Patients With Cancers and Blood Disorders in Iran: Serological Evaluation, Risk Factors and Comparison With Healthy Individuals JO - Journal of Chemical Health Risks VL - 11 IS - 3 SP - 271 EP - 282 PY - 2021 ER - |